Bone Remodeling
Radiographic and Histological Analysis of a Synthetic Bone Graft Substitute Eluting Gentamicin in the Treatment of Chronic Osteomyelitis
Authors: Ferguson et al.
Publication: The Journal of Bone and Joint Infection (2019)
Summary: Patients with chronic osteomyelitis, treated by surgery, implantation of CERAMENT® G, and systemic antibiotics. 138 of these patients had minimum one-year radiographic follow-up (mean 1.7 yrs). 9 patients had subsequent surgery that allowed for histology of biopsies between 19 days-2 years after implantation of CERAMENT® G. Histology “confirmed active remodeling of [CERAMENT® G] into osteoid and lamellar bone”.
Results:
- 163 patients
- 2.5% fracture rate
- 73.8% mean void filling
- 95.7% infection eradication
Autologous Iliac Bone Graft Compared with Biphasic Hydroxyapatite and Calcium Sulfate Cement for the Treatment of Bone Defects in Tibial Plateau Fractures - A Prospective, Randomized, Open-label, Multicenter Study*
Authors: Hofmann et al.
Publication: The Journal of Bone And Joint Surgery (American – 2020)
Summary: This non-inferiority study compared CERAMENT® BONE VOID FILLER to autograft in acute traumatic fractures of the proximal tibia. The study also compared bone remodeling and patient-reported outcome measures between the two treatment groups. *This study featured CERAMENT® BONE VOID FILLER.
Results:
- Proven bone remodeling
- CERAMENT® is as good as autograft
- Less blood loss compared to autograft
- Less post-op pain compared to autograft
- Trend towards shorter duration of surgery
Explore the Studies
Evidence-based Bone Healing
CERAMENT® Autologous Iliac Bone Graft and Healing over 6 months
- Level 1 randomized controlled trial (RCT) – the CERTIFY study involves 135 patients and shows that CERAMENT® BONE VOID FILLER (BVF) is as good as autograft (AIBG) in bone remodeling1*
- One and only orthobiologic product with robust long-term evidence: 94% infection-free after 6 year follow-up2